We are live on ! Find out more

Steris

STE

Market cap $22.6B

232.14 USD

+3.36

1.47%

At close Updated Oct 29, 4:00 PM EDT

Pre-market

After hours

232.14

0.00

0%

1 day

1.47%

5 days

0.58%

1 month

10.2%

3 months

-1.15%

6 months

9.17%

Year to date

-7.16%

1 year

-1.96%

5 years

-0.68%

10 years

247.41%

About: Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.

Employees: 17,937

Healthcare Medical Devices

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 38.1%

Neutral 57.1%

Negative 4.8%

Zacks Investment Research

2 Healthcare Technology Stocks for a Digital Health Boom

GMED and STE offer exposure to healthcare technology growth, with projected 2026 EPS gains, attractive valuations and innovations in essential medical services.

2 Healthcare Technology Stocks for a Digital Health Boom

STERIS Announces Dividend of $0.69 per share

DUBLIN, IRELAND, Oct. 28, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.69 per share. The dividend is payable on December 17, 2026, to shareholders of record at the close of business on November 17, 2026.

STERIS Announces Dividend of $0.69 per share

STERIS to Host a Conference Call for Fiscal 2027 Second Quarter on November 5, 2026

DUBLIN, IRELAND, Oct. 20, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2027 second quarter results at 9:00 a.m. ET on November 5, 2026. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.

STERIS to Host a Conference Call for Fiscal 2027 Second Quarter on November 5, 2026

Zacks Investment Research

Reasons to Add STE Stock to Your Portfolio Right Now

STERIS' strong Healthcare growth, improving AST prospects and rising Life Sciences demand bolster its outlook, despite tariff and inflationary pressures.

Reasons to Add STE Stock to Your Portfolio Right Now

Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)

PITTSBURGH, Oct. 12, 2026 /PRNewswire/ -- Xodus Medical, a leading developer and manufacturer of innovative surgical safety solutions, today announced that it has entered into an agreement to be acquired by STERIS, a global provider of products and services that support patient care with an emphasis on infection prevention. The acquisition represents a significant milestone in Xodus Medical's more than 30-year history, bringing together two organizations with a shared commitment to advancing patient safety, supporting healthcare professionals, and delivering innovative solutions to the surgical environment.

Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)

Steris to Acquire Xodus Medical for $2.1 Billion

The Dublin, Ireland provider of products and services to hospitals and pharmaceutical manufacturers said it expects the deal to expand its portfolio.

Steris to Acquire Xodus Medical for $2.1 Billion

STERIS plc (STE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

STERIS plc (STE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

STERIS plc (STE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Zacks Investment Research

Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?

Steris (STE) reported earnings 30 days ago. What's next for the stock?

Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?

STERIS to Present at the Morgan Stanley Healthcare Conference

Dublin, Ireland, Sept. 01, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Tuesday, September 15, 2026.

STERIS to Present at the Morgan Stanley Healthcare Conference

Zacks Investment Research

Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?

STE is betting $600 million on a new chemistry center to boost capacity and efficiency, but higher spending and execution risks loom.

Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?

See News Rankings

Price charts implemented using Lightweight Charts™